YC

Yipu Capital

Description

Yipu Capital is an investment firm

Investor Profile

Yipu Capital has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Biopharma
  • Biotechnology
  • Medical Device
  • Robotics
  • Automotive
  • Electric Vehicle
  • Hardware
  • Manufacturing
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yipu Capital frequently co-invest with?

Kington Capital
Asia, Jiangsu, China, Suzhou
Co-Investments: 2
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
NRL Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
LongRiver Investments
Asia, Shanghai, China, Xuhui
Co-Investments: 1
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 1
GAC Capital
Asia, Anhui, China, Yuexi
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
EC
North America, New Jersey, United States, North Bergen
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Yipu Capital?

Ronovo Surgical

Shanghai, Shanghai, China

Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.

Health CareMedical DeviceRobotics
Series BAug 30, 2023
Amount Raised: $27,455,179
Qixin Micro Semiconductor

Suzhou, Jiangsu, China

Qixin Micro Semiconductor is a system-on-chip manufacturer mainly engaged in developing and selling high-end smart car controller chips.

AutomotiveElectric VehicleHardwareManufacturingSemiconductor
Series BJun 13, 2022
YS Biopharma

Beijing, Beijing, China

YS Biopharma is a global, fully integrated bio-pharmaceutical company.

BiopharmaBiotechnologyHealth Care
Series BFeb 24, 2021
Amount Raised: $130,000,000
Transcenta

Huangpu, Shanghai, China

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

BiopharmaBiotechnology
Series BJan 8, 2020
Amount Raised: $100,000,000